Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Karyopharm Therapeut (NQ: KPTI )

8.270 USD -0.130 (-1.55%)
Streaming Delayed Price Updated: 2:38 PM EDT, May 10, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 749,854
Open 8.330
Bid (Size) 8.250 (2)
Ask (Size) 8.260 (7)
Prev. Close 8.400
Today's Range 8.150 - 8.400
52wk Range 7.790 - 21.82
Shares Outstanding 75,092,567
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or... 
From PR Newswire
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Compensation Committee of Karyopharm's Board of... 
From PR Newswire

Performance

YTD
-51.12%
-51.12%
1 Month
-17.47%
-17.47%
3 Month
-49.08%
-49.08%
6 Month
-43.28%
-43.28%
1 Year
-59.80%
-59.80%

More News

Read More
Karyopharm Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress
From PR Newswire
Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer
From PR Newswire
Karyopharm to Report First Quarter 2021 Financial Results on May 3, 2021
From PR Newswire
Karyopharm Announces European Medicines Agency's Validation of its Type II Variation Marketing Authorization Application for NEXPOVIO® (selinexor) in Combination with Velcade® (bortezomib) and Dexamet
From PR Newswire
Karyopharm Therapeutics Becomes Oversold (KPTI)
Tags Stocks
From Market News Video
Analysts Forecast 61% Gains Ahead For The Holdings of XBI
Tags ETFs
From ETF Channel
Earnings Preview: Karyopharm Therapeutics
Tags KPTI Market News Earnings
From Benzinga
Karyopharm Therapeutics Inc (KPTI) Q1 2021 Earnings Call Transcript
Tags Market News KPTI
From Motley Fool
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Tags SONN NKTX Guidance
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]